AntineoplasticsSecondary leukaemias: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1845卷 / 1期

关键词：

D O I：

10.1007/s40278-021-91946-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：63 / 63

相关论文

共 50 条

[1] AntineoplasticsSecondary haematological malignancies: 2 case reports
Reactions Weekly, 2010, 1301 (1) : 9 - 9
[2] AntineoplasticsSecondary neoplasms: 4 case reports
Reactions Weekly, 2020, 1787 (1) : 60 - 60
[3] AntineoplasticsSecondary neoplasms: 6 case reports
Reactions Weekly, 2020, 1826 (1) : 57 - 57
[4] AntineoplasticsSecondary malignancies: 8 case reports
Reactions Weekly, 2019, 1782 (1) : 43 - 43
[5] AntineoplasticsSecondary malignancies: 5 case reports
Reactions Weekly, 2017, 1644 (1) : 33 - 33
[6] AntineoplasticsSecondary neoplasms: 4 case reports
Reactions Weekly, 2016, 1594 (1) : 27 - 27
[7] AntineoplasticsSecondary lymphoblastic leukaemia: 3 case reports
Reactions Weekly, 2017, 1672 (1) : 37 - 37
[8] AntineoplasticsSecondary haematological malignancies following breast cancer therapy: 6 case reports
Reactions Weekly, 2006, 1083 (1) : 6 - 7
[9] AntineoplasticsSecondary thyroid cancer (first report for bleomycin, cisplatin and dactinomycin) in patients with osteosarcoma: 2 case reports
Reactions Weekly, 2008, 1197 (1) : 7 - 8
[10] AntineoplasticsSecondary leukaemia, myocardial infarction and chronic obstructive pulmonary disease: 3 case reports
Reactions Weekly, 2017, 1643 (1) : 34 - 34

← 1 2 3 4 5 →